外翻式动脉内膜切除术——闭塞性髂外动脉疾病的一种替代入路
单中心回顾性研究(2000-2020年)纳入47例患者共50例外翻式动脉内膜切除术,用于治疗闭塞性髂外动脉病变(TASC C 22例、TASC D 28例)。技术成功率100%,84%术后即刻症状改善;1、3、5年一期通畅率分别为86%、82%、74%,一期辅助通畅率分别为100%、96%、92%,5年保肢率96%。30天死亡率2%,手术相关并发症10%。作者认为该术式安全有效,5年通畅持久、围手术期并发症和死亡率低。
要点
- 外翻式动脉内膜切除术可用于闭塞性髂外动脉TASC C/D病变,作为腔内和广泛开放搭桥的替代选择。
- 50例中技术成功率100%,84%术后即刻症状改善,5年保肢率96%。
- 1、3、5年一期通畅率86%、82%、74%,一期辅助通畅率100%、96%、92%。
核心结论
- 作者认为外翻式动脉内膜切除术是闭塞性髂外动脉疾病安全、有效的替代治疗,5年通畅持久且围手术期并发症和死亡率低。
研究设计与样本
- 单中心、回顾性综述,纳入2000-2020年间所有因髂外动脉疾病接受外翻式动脉内膜切除术的患者,记录人口学、临床、手术和随访数据。
- 共47例患者接受50例外翻式动脉内膜切除术,中位年龄65.0岁(范围46-82),男性66.6%,68%(n=34)为ASA 3级。
主要发现
- 手术指征为致残性跛行44%、严重肢体缺血56%;血管造影显示TASC C病变22例、TASC D病变28例。
- 中位随访18.5个月(范围0-149),技术成功率100%,84%(n=42)术后即刻症状改善。
- 1、3、5年一期通畅率分别为86%、82%、74%,一期辅助通畅率分别为100%、96%、92%。
- 5年保肢率96%;8例肢体需再干预维持通畅,其中开放2例、腔内3例、杂交3例。
- 30天死亡率2%(n=1),手术相关并发症10%(n=5);随访期间全因死亡率38%(n=19)。
临床怎么用
- 原文未据此给出推荐;作者在结论中认为外翻式动脉内膜切除术是闭塞性髂外动脉疾病安全、有效的替代治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: While endovascular intervention is the recommended first option for management of common iliac artery (CIA) lesions, it lacks durable patency for Trans-Atlantic Inter-Society Consensus (TASC)-II C and D lesions involving the external iliac artery (EIA). Aorto-femoral bypass is a durable option but is unsuitable in patients with significant co-morbidities. Eversion endarterectomy provides an alternative to both endovascular and extensive open aortoiliac reconstruction for occlusive EIA disease. MATERIALS AND METHODS: A single-center, retrospective review (2000-2020) of all patients undergoing eversion endarterectomy for EIA disease was undertaken. Demographic, clinical, operative and follow-up data were recorded. RESULTS: Fifty eversion endarterectomies were performed in 47 patients. The median age was 65.0 years (range 46-82) and 66.6% were male. Sixty-eight percent (n = 34) were ASA grade 3. Indications for intervention were disabling claudication (44%) and critical limb ischaemia (56%). Angiography demonstrated 22 TASC C and 28 TASC D lesions. The median follow-up was 18.5 months (range 0-149). The technical success rate was 100%, and 84% (n = 42) experienced an immediate symptomatic improvement. Primary and primary-assisted patency at one, three and five years was 86%, 82% and 74%, and 100%, 96% and 92%, respectively. The five-year limb salvage rate was 96%. Eight limbs required reintervention to maintain patency, either by open (n = 2), endovascular (n = 3) or hybrid approach (n = 3). Thirty-day mortality was 2% (n = 1) with 10% (n = 5) experiencing a procedure-related morbidity. All-cause mortality was 38% (n = 19) during the follow-up period. CONCLUSIONS: Eversion endarterectomy is a safe, effective alternative treatment for occlusive EIA disease. This study reports durable patency at five years and low perioperative morbidity and mortality.
引用
- Foley MP, Aherne TM, Dooley C, et al. Eversion Endarterectomy - An Alternative Approach to Occlusive External Iliac Artery disease. Ann Vasc Surg. 2021. PMID: 34954032. doi:10.1016/j.avsg.2021.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。